86300 Immunoassay tumor ca 15-3
Also known as: CA 15-3, carbohydrate antigen 15-3
Carbohydrate antigen 15-3 (CA 15-3) immunoassay quantitatively measures tumor-associated antigen primarily used in breast cancer monitoring and prognosis.
In Plain Language
Breast cancer marker; Tumor progression indicator
Clinical Context
Measured for monitoring breast cancer treatment response and detecting recurrence. Elevated levels indicate disease progression but not specific for breast cancer.
RVU Information
CPT 86300 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Lab and pathology codes require an order from the treating provider with clinical indication. For molecular pathology and genetic testing, document the specific analytes tested and clinical rationale.
How This Code Compares
This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the Pathology & Lab category, 94% of codes share this characteristic.
Specialties
Frequently Asked Questions
What is CPT code 86300?
CPT 86300 (Immunoassay tumor ca 15-3) is a Pathology & Lab code. Carbohydrate antigen 15-3 (CA 15-3) immunoassay quantitatively measures tumor-associated antigen primarily used in breast cancer monitoring and prognosis.
Who uses CPT code 86300?
CPT 86300 is used by Oncology, Clinical Pathology, Immunology. Measured for monitoring breast cancer treatment response and detecting recurrence. Elevated levels indicate disease progression but not specific for breast cancer.
When is CPT 86300 used?
Measured for monitoring breast cancer treatment response and detecting recurrence. Elevated levels indicate disease progression but not specific for breast cancer.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.